Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Avadel Pharmaceuticals plc (AVDL)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
6.75-0.06 (-0.88%)
At close: 04:00PM EDT
6.95 +0.20 (+2.96%)
After hours: 04:00PM EDT
Advertisement

Avadel Pharmaceuticals plc

10 Earlsfort Terrace
Dublin 2
Ireland
353 1 901 5201
https://www.avadel.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees66

Key Executives

NameTitlePayExercisedYear Born
Mr. Gregory J. Divis Jr.CEO & Director862.59kN/A1967
Mr. Thomas S. McHughSr. VP & CFO550kN/A1965
Mr. Richard KimChief Commercial Officer596.3kN/A1969
Mr. Jerad G. SeurerGen. Counsel & Company Sec.N/AN/AN/A
Mr. Gregory J. DavisVP of Corp. and Bus. Devel.N/AN/A1965
Mr. Mark W. ElrodVP of SalesN/AN/AN/A
Ms. Angie WoodsVP of People & CultureN/AN/AN/A
Mr. Christian Kalita Pharm.DChief Pharmacist and Director of Quality Assurance & Regulatory AffairsN/AN/AN/A
Mr. Steven G. SullivanVP of Sales & Marketing and Head of Commercial OperationsN/AN/A1965
Dr. Jordan S. Dubow M.D.ConsultantN/AN/A1978
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.

Corporate Governance

Avadel Pharmaceuticals plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement